(BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard University today announced the launch of its latest startup company, Ultivue Inc. Ultivue will introduce imaging reagents providing super-resolution capabilities on standard single-molecule microscopes similar to those of expensive specialized instruments. The announcement follows a worldwide licensing agreement between Harvard’s Office of Technology Development […]
SOUTH SAN FRANCISCO, Calif. — The Warrington, Great Britain manufacturing site for Thermo Fisher Scientific now meets the guidelines for 18385 certification, a new standard proposed by the International Organization for Standardization (ISO). By achieving this milestone, the company helps set a new standard for manufacturing key products and technologies that international forensic laboratories rely […]
BRISBANE, Australia and SAN DIEGO — UniQuest, the main technology transfer and commercialisation company of TheUniversity of Queensland (UQ), has signed an exclusive worldwide licensing agreement with Organovo Holdings, Inc. (NYSE MKT:ONVO), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, to patent applications relating to methodology for […]
CAMBRIDGE, Mass. — Ultivue, an early stage life sciences tools company, today announced the completion of $5.15 million in Series A financing from a group of investors including ARCH Venture Partners, Hansjoerg Wyss, and several private investors. Ultivue is based on DNA-PAINT and DNA-Exchange technologies developed at the Wyss Institute for Biologically Inspired Engineering at […]
NEW YORK, NY – Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has reached and finalized a settlement with Affymetrix, Inc. (NASDAQ: AFFX) involving payment of $10 million to Enzo in an infringement action brought by Enzo regarding its U.S. Patent No. 7,064,197. Today’s settlement resolving the disputes between Enzo and Affymetrix impacts only one […]
BALTIMORE, MD – Circulomics Inc has been awarded a $1.5M Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH) – National Institute of General Medical Sciences (NIGMS) to develop its Ligo-miR microRNA assay platform. This award follows a previous $400k Phase I award and will create a comprehensive portfolio […]
Schlieren, Switzerland — InSphero AG, the leading supplier of easy-to-use solutions for production, culture, and assessment of organotypic 3D cell culture models, has launched a 14 Day Hepatotoxicity Testing Servicedesigned to meet increased demand for contract screening in their patent-pending 3D InSight™ Human Liver Microtissues. The service streamlines toxicity testing of compounds in InSphero’s 3D […]
AMSBIO has announced a new PD-1 (Programmed Death) inhibitor screening assay kit for cancer research studies. Immunotherapy for the treatment of cancer is rapidly evolving from therapies that globally and non-specifically simulate the immune system to more targeted activation of individual components of the immune system. The net result of this targeted approach is decreased […]
LEIDEN – BIOKÉ, a Cell Signaling Technology Europe (CST Europe) company, and Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), the international life science company supplying research tools and services that power genomics research and the development of personalized medicines, announced that they have signed an exclusive agreement allowing BIOKE to distribute Horizon’s […]
MANASSAS, Va.– ATCC, the premier global biological materials resource and standards organization, announces today that it has been selected by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to provide vital cell lines to academic, pharmaceutical, and biotechnology organizations committed to speed a cure for Parkinson’s disease. Parkinson’s disease is a chronic, degenerative neurological […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
